ITLN1
Intelectin-1
Also known as: FLJ20022, hIntL, HL-1, ITLN, ITLN1_HUMAN, LFR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WWA0
- Gene
- ITLN1
- Ensembl
- ENSG00000179914
- Chromosome
- 1
- Canonical length
- 313 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Subcellular location
- Vesicles,Acrosome,Equatorial segment,Mid piece,Principal piece
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
Enables calcium ion binding activity; identical protein binding activity; and oligosaccharide binding activity. Involved in positive regulation of D-glucose import; positive regulation of protein phosphorylation; and protein homotrimerization. Located in extracellular exosome. Part of receptor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
313 residues, UniProt reviewed canonical sequence.
>Q8WWA0|ITLN1
1 MNQLSFLLFL IATTRGWSTD EANTYFKEWT CSSSPSLPRS CKEIKDECPS AFDGLYFLRT
61 ENGVIYQTFC DMTSGGGGWT LVASVHENDM RGKCTVGDRW SSQQGSKAVY PEGDGNWANY
121 NTFGSAEAAT SDDYKNPGYY DIQAKDLGIW HVPNKSPMQH WRNSSLLRYR TDTGFLQTLG
181 HNLFGIYQKY PVKYGEGKCW TDNGPVIPVV YDFGDAQKTA SYYSPYGQRE FTAGFVQFRV
241 FNNERAANAL CAGMRVTGCN TEHHCIGGGG YFPEASPQQC GDFSGFDWSG YGTHVGYSSS
301 REITEAAVLL FYRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITLN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 1,173 nTPM
Expression across tissuesHPA
Tissue
- rectum: 1,173 nTPM
- adipose tissue: 715 nTPM
- colon: 417 nTPM
- small intestine: 391 nTPM
- duodenum: 257 nTPM
- heart muscle: 220 nTPM
Single-cell type
- mesothelial cells: 8,632 nCPM
- goblet cells: 1,958 nCPM
- kupffer cells: 358 nCPM
- thymic myoid cells: 109 nCPM
- medullary thymic epithelial cells: 58 nCPM
- fibro-adipogenic progenitors: 47 nCPM
Immune cell
- non-classical monocyte: 24 nTPM
- intermediate monocyte: 9.2 nTPM
- myeloid DC: 1.4 nTPM
- classical monocyte: 0.5 nTPM
- total PBMC: 0.4 nTPM
- neutrophil: 0.2 nTPM
Brain region
- cerebral cortex: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of D-glucose import
- positive regulation of protein phosphorylation
- protein homotrimerization
- response to nematode
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITLN1 as an antibody target. Whether an autoantibody or antibody against ITLN1 could matter depends on whether native ITLN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITLN1 is annotated at the cell surface, where native ITLN1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ITLN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...